Apex Bioventures Acquisition Corp. Announces Stockholder Approval to Liquidate and Dissolve

Name	Symbol	Market	Type
ProShares Global Listed Private Equity	AMEX:PEX	AMEX	Exchange Traded Fund

Name

Symbol

Market

Type

ProShares Global Listed Private Equity

AMEX:PEX

AMEX

Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.1666	0.58%	28.835	28.88	28.76	28.86	1,537	21:15:00

Price Change

% Change

Price

High Price

Low Price

Open Price

Traded

Last Trade

0.1666

0.58%

28.835

28.88

28.76

28.86

1,537

21:15:00

Apex Bioventures Acquisition Corp. Announces Stockholder Approval to Liquidate and Dissolve

02/06/2009 7:30pm

PR Newswire (US)

ProShares Global Listed ... (AMEX:PEX)
Historical Stock Chart

From Nov 2019 to Nov 2024

Click Here for more ProShares Global Listed ... Charts.

HILLSBOROUGH, Calif., June 2 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced that at a special meeting of stockholders held today, the Company's stockholders voted to approve the Company's previously-announced dissolution and proposed Plan of Liquidation. As of the close of business on June 2, 2009, the Company's share transfer books will close and the NYSE Amex LLC will suspend trading. Pursuant to the plan of liquidation, the Company expects to liquidate its trust account, which consists of proceeds from the Company's private placement of warrants and initial public offering and the interest accumulated thereon, including the deferred portion of the underwriters' fee held in the trust account following consummation of the public offering. Liquidating distributions from the trust account are payable upon presentation to holders of shares of common stock issued in the Company's initial public offering that hold such shares as of the close of business on June 2, 2009. The liquidating distribution is expected to be approximately $7.84 per share. No payments will be made with respect to any of the Company's outstanding warrants or shares that were acquired prior to the Company's initial public offering. The Company has filed a certificate of dissolution with the Secretary of State of the State of Delaware and will be filing a Certification and Notice of Termination of Registration on Form 15 with the Securities and Exchange Commission for the purpose of deregistering its securities under the Securities Exchange Act of 1934. The Company will no longer be a public reporting company and its securities will no longer trade on the NYSE Amex LLC. DATASOURCE: Apex Bioventures Acquisition Corporation CONTACT: Darrell J. Elliott, Chairman and Chief Executive Officer, +1-604-924-0349; or K. Michael Forrest, President and Chief Operating Officer, +1-650-344-3029, both of Apex Bioventures Acquisition Corporation

	Real-time Prices	Level 2
London Stock Exchange
Chi-X Europe
BATS Europe
Aquis Exchange
New York Stock Exchange
NASDAQ
American Stock Exchange
Dow Jones Indices
Precious Metal

London Stock Exchange
Advanced charts
Premium community
Data download

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

PEX ProShares Global Listed Private Equity